MedTrace Logo

Thirty Day Heart Monitoring for Detection of Atrial Fibrillation Among Cryptogenic Stroke Patients

NCT03712865 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 232

Last updated 2022-05-18

No results posted yet for this study

Summary

The PROPhecy study aims to detect the presence of atrial fibrillation/flutter in patients who have suffered an embolic stroke of undetermined source (ESUS) using 30 day cardiac monitoring.

We hypothesize that the presence of any of the following features on long-term heart rhythm monitoring (holter monitoring) or heart ultrasound (transthoracic echocardiogram), either individually or in combination, will have additional predictive value for the detection of atrial fibrillation lasting 30 seconds or longer on 30 day holter monitoring:

* greater than 100 premature atrial beats in 24 hours
* greater than 2 runs of atrial tachycardia (4 or more non-sinus beats) in 24 hours
* Left atrial enlargement on transthoracic echocardiogram

Conditions

  • Embolic Stroke of Undetermined Source

Sponsors & Collaborators

Principal Investigators

  • Thalia S Field, MD FRCPC · University of British Columbia

Eligibility

Min Age
55 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-11-19
Primary Completion
2022-03-03
Completion
2022-03-03

Countries

  • Canada

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03712865 on ClinicalTrials.gov